telehealth.helpFind my match

Home WikiTelehealth Conditions

Obesity

From WikiTelehealth, the telehealth.help reference · Last updated

Obesity is a chronic disease in which a person has excess body fat that can harm health, defined in adults as a body mass index (BMI) of 30 or greater. About 40.3% of US adults had obesity in August 2021 to August 2023, according to the CDC.

Obesity
TypeChronic disease
Adult definitionBMI of 30 or greater
Severe obesityBMI of 40 or greater
US adults with obesity40.3% (2021-2023)
US adults with severe obesity9.4% (2021-2023)
TreatmentsLifestyle, medicines, surgery

Definition

Obesity is defined in adults by body mass index (BMI). A BMI of 30 or greater is obesity, and a BMI of 40 or greater is called severe obesity (class 3). BMI is a screening tool, so clinicians also look at waist size and other health measures.

The CDC describes obesity as a serious, common and costly chronic disease. Many medical groups treat it as a long-term condition that needs ongoing care, in the same way as high blood pressure or diabetes.

Prevalence in the United States

National survey data from August 2021 to August 2023 found that 40.3% of US adults had obesity and 9.4% had severe obesity. Rates of obesity were similar in men and women. Severe obesity was more common in women. Adult obesity has risen since 1999 to 2000, when about 30.5% of adults had obesity.

Health effects

Obesity raises the risk of many other conditions. These include type 2 diabetes, high blood pressure, heart disease, stroke, sleep apnea, fatty liver disease, some cancers and joint problems. The CDC reports that many adults with obesity also have diabetes or heart disease.

Treatment

Treatment for obesity often starts with changes in eating, physical activity and sleep. Behavioral programs can help people make these changes. For some adults, a prescriber may add a medicine. Medicines approved by the FDA for long-term weight management include orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide, semaglutide, tirzepatide and orforglipron. Weight-loss (bariatric) surgery is an option for some people with higher BMI.

GLP-1 medicines have become a common choice. In the STEP 1 trial, adults on semaglutide 2.4 mg lost 14.9% of their body weight on average after 68 weeks. In SURMOUNT-1, adults on the highest dose of tirzepatide lost 20.9% after 72 weeks. For a side-by-side look at online programs that prescribe these drugs, see our comparison of GLP-1 providers.

Compare online GLP-1 programs

See also

References

  1. CDC, Adult obesity facts. cdc.gov
  2. CDC NCHS Data Brief No. 508, Obesity and severe obesity prevalence in adults: United States, August 2021-August 2023. cdc.gov
  3. NIDDK, Prescription medications to treat overweight and obesity. niddk.nih.gov
  4. Wilding JPH et al., "Once-weekly semaglutide in adults with overweight or obesity" (STEP 1), NEJM 2021. doi.org
  5. Jastreboff AM et al., "Tirzepatide once weekly for the treatment of obesity" (SURMOUNT-1), NEJM 2022. doi.org

Last updated . Category: Conditions. Browse all 38 WikiTelehealth entries.